NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Instruments & Supplies · USD

The Cooper Companies, Inc. (COO) Stock Analysis

The Cooper Companies, Inc. (COO) is a Medical Instruments & Supplies stock listed on NASDAQ and quoted in US Dollar.

COO

$69.59

−$1.05 (−1.49%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare COO with… →

COO Key Statistics

As of Sep 4, 2026
Trading
Open
$70.33
Previous Close
$70.64
Day's Range
69.51–70.48
52-Week Range
58.89–89.83
Volume
1.96M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.82
Valuation
Market Cap
$13.57B
P/E Ratio
58.97
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
13.93
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.67
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.21
EPS (ttm)Profit attributable to each share over the last twelve months.
1.18
Financials (FY)
Revenue (FY)
$4.09B+5.06%
Net Income (FY)
$374.90M−4.44%
Profit marginThe share of revenue left as profit after all costs and taxes.
5.57%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
195.03M
1-Year Return
+2.34%
Dividend and dates
Earnings Date
September 9, 2026
Avg Volume
2.35M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

COO Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−15.09%
2025−10.85%
2024−2.83%
2023+14.47%
2022−21.06%
2021+15.33%
2020+13.10%
2019+26.27%
2018+16.84%
2017+24.59%
2016 (partial year)−3.51%

As of September 4, 2026.

COO Revenue and Earnings by Fiscal Year

FY ends October
Fiscal yearRevenueNet incomeNet margin
2025$4.09B$374.90M9.2%
2024$3.90B$392.30M10.1%
2023$3.59B$294.20M8.2%
2022$3.31B$385.80M11.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$4.09B$2.68B$682.90M$374.90M9.2%
2024$3.90B$2.60B$705.70M$392.30M10.1%
2023$3.59B$2.36B$533.10M$294.20M8.2%
2022$3.31B$2.14B$507.60M$385.80M11.7%

Annual figures as reported, in the company's reporting currency. As of October 31, 2025.

COO Valuation vs Medical Instruments & Supplies Median

Median of 55 stocks
MetricCOOMedical Instruments & Supplies medianvs median
P/E58.9735.6166% above
P/S ratio3.213.171% above
Profit margin5.57%0.85%4.7 pts above

Medians across 55 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 15 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The Cooper Companies, Inc. (COO) carries a market capitalisation of $13.57B. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. Headcount on file is 15,000.

Over the past 52 weeks the price has ranged from $58.89 to $89.83. The most recent close on file for COO is $69.59, dated September 4, 2026. That is −$1.05 (−1.49%) against the previous close. The latest close sits 18.17% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $4.09B. That is +5.06% against the prior fiscal year, when revenue was $3.90B. Net income for the same year was $374.90M. That is −4.44% against the prior fiscal year. Profit margin runs at 5.57%. That is 4.7 percentage points above the Medical Instruments & Supplies median of 0.85%. Trailing earnings per share are 1.18.

Across the 4 fiscal years on file, revenue moves from $3.31B in 2022 to $4.09B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 58.97 times earnings. That is 65.58% above the Medical Instruments & Supplies median of 35.61. On forward earnings the ratio is 13.93. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.67. The price-to-sales ratio is 3.21. On price-to-sales that is 1.1% above the Medical Instruments & Supplies median of 3.17. 55 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

The reported beta is 0.82. Annualized volatility over the trailing 10 years is 28.05%. The trailing one-year price return is +2.34%. Measured over 10 years, that is +4.13% a year compounded.

Growth & Income

No dividend is on file for COO.

The strongest complete calendar year on file is 2019 at +26.27%; the weakest is 2022 at −21.06%. Of the 9 complete calendar years on file, 6 finished higher. 2026 is still running; the price is −15.09% year to date.

Peer Comparison

The Cooper Companies, Inc. (COO) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
The Cooper Companies, Inc. COO $13.57B 59.0
Intuitive Surgical, Inc. ISRG $131.38B 42.4
Becton, Dickinson and Company BDX $50.32B 32.0
Medline Inc. MDLN $49.23B 45.7

The Medical Instruments & Supplies industry average P/E ratio is 35.6x. The Cooper Companies, Inc. trades at a P/E of 59.0.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$131.38B

 BDX

Becton, Dickinson and Company

$50.32B

 MDLN

Medline Inc.

$49.23B

 ALC

Alcon Inc.

$34.08B

 RMD

ResMed Inc.

$32.94B

 WST

West Pharmaceutical Services, Inc.

$23.93B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About The Cooper Companies, Inc.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Visit website →